Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott Davis

Showing results (271-280 of 294) with videos related to

Pageof 30
Sort By:
Carcinogenesis|November 26, 2008
A pooled investigation of Toll-like receptor gene variants and risk of non-Hodgkin lymphomaMark P Purdue, Qing Lan, Sophia S Wang, et al.
International Journal of Molecular Epidemiology and Genetics|September 15, 2011
Immunostaining to identify molecular subtypes of diffuse large B-cell lymphoma in a population-based epidemiologic study in the pre-rituximab eraLindsay M Morton, James R Cerhan, Patricia Hartge, et al.
British Journal of Haematology|September 4, 2010
Polymorphisms in DNA repair genes and risk of non-Hodgkin lymphoma in a pooled analysis of three studiesMin Shen, Idan Menashe, Lindsay M Morton, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 28, 2025
Pharmacokinetics, lineage identity, and trafficking of ex vivo expanded polyclonal regulatory T cells in a prospective randomized clinical trial of kidney transplant recipients with allograft inflammationSindhu Chandran, Joey C Leung, Alexander Vu, et al.
Journal of Medicinal Chemistry|October 27, 2010
In vivo characterization of a dual adenosine A2A/A1 receptor antagonist in animal models of Parkinson's diseaseBrian C Shook, Stefanie Rassnick, Melville C Osborne, et al.
Nature Communications|February 17, 2017
microRNA-17 family promotes polycystic kidney disease progression through modulation of mitochondrial metabolismSachin Hajarnis, Ronak Lakhia, Matanel Yheskel, et al.
Molecular Cancer Research : MCR|March 12, 2015
Anti-miR-21 Suppresses Hepatocellular Carcinoma Growth via Broad Transcriptional Network DeregulationTimothy R Wagenaar, Sonya Zabludoff, Sung-Min Ahn, et al.
Journal of Radiological Protection : Official Journal of the Society for Radiological Protection|June 2, 2006
Cancer consequences of the Chernobyl accident: 20 years onElisabeth Cardis, Geoffrey Howe, Elaine Ron, et al.
Science (New York, N.Y.)|May 3, 2014
Polarization of the effects of autoimmune and neurodegenerative risk alleles in leukocytesTowfique Raj, Katie Rothamel, Sara Mostafavi, et al.
Blood|September 18, 2008
Etiologic heterogeneity among non-Hodgkin lymphoma subtypesLindsay M Morton, Sophia S Wang, Wendy Cozen, et al.
Pageof 30

Showing results (271-280 of 294) with videos related to

Sort By:
Pageof 30
Carcinogenesis|November 26, 2008
A pooled investigation of Toll-like receptor gene variants and risk of non-Hodgkin lymphomaMark P Purdue, Qing Lan, Sophia S Wang, et al.
International Journal of Molecular Epidemiology and Genetics|September 15, 2011
Immunostaining to identify molecular subtypes of diffuse large B-cell lymphoma in a population-based epidemiologic study in the pre-rituximab eraLindsay M Morton, James R Cerhan, Patricia Hartge, et al.
British Journal of Haematology|September 4, 2010
Polymorphisms in DNA repair genes and risk of non-Hodgkin lymphoma in a pooled analysis of three studiesMin Shen, Idan Menashe, Lindsay M Morton, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 28, 2025
Pharmacokinetics, lineage identity, and trafficking of ex vivo expanded polyclonal regulatory T cells in a prospective randomized clinical trial of kidney transplant recipients with allograft inflammationSindhu Chandran, Joey C Leung, Alexander Vu, et al.
Journal of Medicinal Chemistry|October 27, 2010
In vivo characterization of a dual adenosine A2A/A1 receptor antagonist in animal models of Parkinson's diseaseBrian C Shook, Stefanie Rassnick, Melville C Osborne, et al.
Nature Communications|February 17, 2017
microRNA-17 family promotes polycystic kidney disease progression through modulation of mitochondrial metabolismSachin Hajarnis, Ronak Lakhia, Matanel Yheskel, et al.
Molecular Cancer Research : MCR|March 12, 2015
Anti-miR-21 Suppresses Hepatocellular Carcinoma Growth via Broad Transcriptional Network DeregulationTimothy R Wagenaar, Sonya Zabludoff, Sung-Min Ahn, et al.
Journal of Radiological Protection : Official Journal of the Society for Radiological Protection|June 2, 2006
Cancer consequences of the Chernobyl accident: 20 years onElisabeth Cardis, Geoffrey Howe, Elaine Ron, et al.
Science (New York, N.Y.)|May 3, 2014
Polarization of the effects of autoimmune and neurodegenerative risk alleles in leukocytesTowfique Raj, Katie Rothamel, Sara Mostafavi, et al.
Blood|September 18, 2008
Etiologic heterogeneity among non-Hodgkin lymphoma subtypesLindsay M Morton, Sophia S Wang, Wendy Cozen, et al.
Pageof 30